Neuroimmune Advance in Depressive Disorder

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Major depressive disorder (MDD) is a prevalent, chronic, and recurrent condition with significant disease burden and social impairment.
• Immune molecules and cells are implicated in MDD's pathophysiology and maintenance.
• Neuroinflammation, involving both pro- and anti-inflammatory cytokines, contributes to depressive symptoms and disease course.

Purpose of the Study:

• To explore the role of neuroinflammation in the pathogenesis of MDD.
• To investigate the link between neuroinflammation and key biological systems (stress response, neuroendocrine, neurotransmission, neurogenesis, gut microbiota).
• To highlight the potential of anti-inflammatory interventions in MDD treatment.

Main Methods:

• Review of animal and human patient findings.
• Analysis of evidence linking neuroinflammation to MDD.
• Examination of the role of cytokines in depression.

Main Results:

• Neuroinflammation is a key mediator connecting stress, neuroendocrine, neurotransmission, neurogenesis, and gut microbiota.
• These interconnected systems are recognized risk factors in MDD pathogenesis.
• Evidence suggests inflammatory processes are involved in MDD development and progression.

Conclusions:

• Neuroinflammation plays a critical role in the complex pathophysiology of MDD.
• Interventions targeting inflammatory pathways represent a promising therapeutic strategy for MDD.